CureMeAbroad, an AI-driven medical tourism discovery platform based in Pune, has secured $600,000 in a pre-seed funding round to accelerate its expansion.
The round saw backing from notable investors including Dr Roman Saini, Himanshu Ratnoo, Kunal Gupta, Devaiah Bopanna, Vikrant Potnis, along with AIRA Buildon.
Founded in June 2025 by Aditya Oza and Mikhail Bohra, the startup focuses on cross-border healthcare—a segment the founders believe remains largely underdeveloped despite its scale.
Globally, around 14 million patients travel overseas for treatment every year, with the market expected to grow to $174 billion by 2035. However, the founders highlight persistent gaps such as poor price transparency, reliance on middlemen, lack of verified providers, and weak post-treatment care systems.
“There is no Booking.com for medical tourism, and for an industry touching 14 million lives every year, that is not a gap in the market, it is a failure of the global healthcare system,” said Aditya Oza.
“Patients should not be making the biggest decisions of their lives on forwarded WhatsApp messages. We set out to build the trust layer that the category has been missing. This is one of those rare problems where the impact is measured in millions of lives, and billions of dollars, and our ambition for CureMeAbroad is genuinely global,” he added.
The platform currently features over 6,000 hospitals across 47 countries and 45 specialties, and works with more than 380 accredited hospitals in key destinations such as Mexico, Turkey, Thailand, India, and Georgia.
Investor confidence is also tied to Oza’s past execution. “Backing Aditya again was the easiest decision I have had to make as an investor,” said Kunal Gupta.
“I worked alongside him for years at EMotorad. I watched him take a Pune startup with no capital and no distribution and help turn it into a globally recognised brand across 18 countries. The same instincts that worked there, thinking global from day one, treating consumer trust as the moat, obsessing over detail, are exactly what medical tourism has been waiting for. And the current traction in two quarters tells you he has already translated those instincts into this new category,” he said.
The newly raised funds will be used to strengthen its technology stack, including enhancements to its AI-based cost estimation tools, clinical matching systems, and multilingual patient intelligence engine.
The company also plans to scale its presence in key regions, starting with the GCC, UK, and Africa.
“This round is about going deeper on tech, sharper on team, and wider on growth,” said Aditya.
CureMeAbroad is also in discussions with institutional investors as it prepares for its next seed funding round.
As it gears up for its next phase, CureMeAbroad is positioning itself to bring greater transparency, trust, and efficiency to global medical travel. With fresh capital and growing investor confidence, the startup aims to simplify cross-border healthcare decisions for millions of patients worldwide.
(Photo courtesy: X/entrackr)